1. Home
  2. PDSB vs ESLA Comparison

PDSB vs ESLA Comparison

Compare PDSB & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.88

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.53

Market Cap

48.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDSB
ESLA
Founded
2005
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.5M
48.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDSB
ESLA
Price
$0.88
$1.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.00
$16.00
AVG Volume (30 Days)
592.3K
127.6K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.73
52 Week High
$2.20
$3.15

Technical Indicators

Market Signals
Indicator
PDSB
ESLA
Relative Strength Index (RSI) 49.68 41.96
Support Level $0.86 $1.46
Resistance Level $0.93 $1.62
Average True Range (ATR) 0.07 0.21
MACD -0.00 -0.02
Stochastic Oscillator 11.26 16.67

Price Performance

Historical Comparison
PDSB
ESLA

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: